Data spanning the past 90 days through February 10, 2026 reveals that Protara Therapeutics's three principal insider shareholders consist of Ceo And President Jesse Shefferman (1.02Mn shares), Director Luke M Beshar (198.00K shares), Chf Scientific Operations Off Jacqueline Zummo (118.56K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Jesse Shefferman | Ceo And President | 1,021,832 | 27 Jan, 2026 |
| Luke M Beshar | 198,000 | 05 Jul, 2022 | |
| Jacqueline Zummo | Chf Scientific Operations Off | 118,559 | 27 Jan, 2026 |
| Leonardo Viana Nicacio | Chief Medical Officer | 78,181 | 21 Jan, 2026 |
| William Conkling | Chief Commercial Officer | 76,000 | 21 Jan, 2026 |
| Patrick Fabbio | Chief Financial Officer | 64,115 | 27 Jan, 2026 |
| Jathin Bandari | Chief Medical Officer | 56,704 | 23 Jan, 2024 |
| Richard S Levy | 51,000 | 19 May, 2025 | |
| Management Inc. Opaleye | 45,000 | 12 Sep, 2024 | |
| Hannah Fry | Vp And Controller | 42,723 | 27 Jan, 2026 |
| Blaine Davis | Chief Financial Officer | 20,662 | 19 Jul, 2022 |
| Martin Sebastian Olivo | Chief Medical Officer | 14,344 | 14 Jun, 2021 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 26 Jan, 2026 | Patrick Fabbio | Common Stock | D | 3,261 | $6.67 | 64,115 | D | F |
| 26 Jan, 2026 | Jacqueline Zummo | Common Stock | D | 3,724 | $6.67 | 118,559 | D | F |
| 26 Jan, 2026 | Jesse Shefferman | Common Stock | D | 8,732 | $6.67 | 1,021,832 | D | F |
| 26 Jan, 2026 | Hannah Fry | Common Stock | D | 1,457 | $6.67 | 42,723 | D | F |
| 20 Jan, 2026 | Patrick Fabbio | Common Stock | D | 3,063 | $5.60 | 67,376 | D | F |
| 20 Jan, 2026 | Jacqueline Zummo | Common Stock | D | 6,578 | $5.60 | 122,283 | D | F |
| 20 Jan, 2026 | Jesse Shefferman | Common Stock | D | 16,322 | $5.60 | 1,030,564 | D | F |
| 20 Jan, 2026 | Hannah Fry | Common Stock | D | 2,132 | $5.60 | 44,180 | D | F |
| 16 Jan, 2026 | Patrick Fabbio | Common Stock | A | 28,000 | $0.00 | 70,439 | D | A |
| 16 Jan, 2026 | Jacqueline Zummo | Common Stock | A | 30,000 | $0.00 | 128,861 | D | A |
| 16 Jan, 2026 | Jesse Shefferman | Common Stock | A | 87,000 | $0.00 | 1,046,886 | D | A |
| 16 Jan, 2026 | William Conkling | Common Stock | A | 26,000 | $0.00 | 76,000 | D | A |
| 16 Jan, 2026 | Hannah Fry | Common Stock | A | 9,500 | $0.00 | 46,312 | D | A |
| 16 Jan, 2026 | Leonardo Viana Nicacio | Common Stock | A | 26,000 | $0.00 | 78,181 | D | A |
| 27 Jun, 2025 | Jesse Shefferman | Common Stock | D | 3,367 | $0.00 | 959,886 | D | G |
| 27 Jun, 2025 | Jesse Shefferman | Common Stock | D | 10,200 | $0.00 | 963,253 | D | G |
| 26 Jun, 2025 | Jesse Shefferman | Common Stock | D | 3,400 | $0.00 | 973,453 | D | G |
| 26 Jun, 2025 | Jesse Shefferman | Common Stock | D | 1,700 | $0.00 | 976,853 | D | G |
| 24 Jun, 2025 | Jesse Shefferman | Common Stock | D | 300,000 | $0.00 | 659,886 | D | G |
| 02 Jun, 2025 | William Conkling | Common Stock | A | 50,000 | $0.00 | 50,000 | D | A |